Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BGI Genomics : Chinese genetics company BGI denies U.S. human rights accusations

07/22/2020 | 12:52am EST

The Chinese parent of two companies added to a U.S. economic blacklist over allegations of conducting genetic analyses used to further the repression of China's minority Uighurs has denied wrongdoing.

"BGI Group does not engage in unethical practices and does not provide gene technology for the surveillance of Uighurs. BGI Group does not condone and would never be involved in any human-rights abuses," a company statement said on Tuesday.

The statement came after the U.S. Commerce Department on Monday added 11 Chinese companies to its economic blacklist over China's treatment of its Uighurs in Xinjiang in western China.

The companies included two units of BGI, or the Beijing Genomics Institute.

One subsidiary named, Xinjiang Silk Road BGI, "was established in November 2016 and has not carried out actual business so far," BGI said. The other, "Beijing Liuhe BGI" provides commercial gene synthesis for researchers and scientists, the company statement added, saying it is unclear "how its services or products could be used with respect to the allegations made."

The Commerce Department, which did not immediately respond to a request for comment on Tuesday, said the two BGI units were being added for "conducting genetic analyses used to further the repression of Uighurs and other Muslim minorities."

The companies added to the blacklist Monday include Nanchang O-Film Tech, a supplier for Apple's iPhone, which hosted Apple chief executive Tim Cook in December 2017, according to O-Film's website.

Apple spokesman Josh Rosenstock said Tuesday the company has "found no evidence of any forced labor on Apple production lines and we plan to continue monitoring."

Apple has "worked with O-Film for several years and have regularly conducted detailed audits of their facilities," Rosenstock said, adding "Apple is dedicated to ensuring everyone in our supply chain is treated with dignity and respect."

U.S. Senator Marco Rubio, a Republican, praised the Commerce Department's designations "to ensure that U.S. technology does not aid the Chinese Communist Party's crimes against humanity and egregious human rights abuses against Uighurs and other minorities in Xinjiang, including the forced collection of DNA."

By David Shepardson


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
APPLE INC. 0.75% 116.03 Delayed Quote.55.08%
BGI GENOMICS CO., LTD. 0.26% 129.63 End-of-day quote.88.69%
All news about BGI GENOMICS CO., LTD.
09/23China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
09/23China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
08/27BGI GENOMICS : WHO says it is in talks with China's BGI on test kit after Swedis..
RE
08/26BGI GENOMICS : China's BGI defends COVID-19 test kit after Swedish criticism
RE
08/24BGI GENOMICS CO., LTD. : half-yearly earnings release
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
07/22BGI GENOMICS : Chinese genetics company BGI denies U.S. human rights accusations
RE
07/21U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/20U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/14BGI GENOMICS : China's BGI forecasts 700% jump in first-half profit due to COVID..
RE
More news
Financials
Sales 2020 8 985 M 1 366 M 1 366 M
Net income 2020 3 530 M 537 M 537 M
Net Debt 2020 - - -
P/E ratio 2020 14,7x
Yield 2020 0,15%
Capitalization 51 346 M 7 809 M 7 808 M
Capi. / Sales 2020 5,71x
Capi. / Sales 2021 9,58x
Nbr of Employees -
Free-Float 100,0%
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price
Last Close Price 129,63 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Ye Yin General Manager & Director
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Yi Qing Chen Chief Financial Officer
Jun Wang Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.88.69%7 770
EXACT SCIENCES CORPORATION26.80%18 648
GUARDANT HEALTH, INC.44.61%11 297
INVITAE CORPORATION189.21%8 243
ADAPTIVE BIOTECHNOLOGIES CORPORATION50.43%6 156
IOVANCE BIOTHERAPEUTICS, INC.34.25%5 451